Genomes and Genes
- Clinical baseline factors predict response to natalizumab: their usefulness in patient selectionAlice Laroni
Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Largo Daneo 3, 16132 Genova, Italy
BMC Neurol 14:103. 2014..Optimal patient selection would improve the risk-benefit ratio of natalizumab treatment for relapsing-remitting multiple sclerosis (RR MS). Clinical features of subjects responding to natalizumab have not been univocally recognized...
- Cytokine polymorphisms and Alzheimer disease: possible associationsG Ribizzi
Department of Neurology, Ospedale S Martino, L go R Benzi, 10, 16100, Genoa, Italy
Neurol Sci 31:321-5. 2010..Large cohort studies are necessary in order to assess the real association of some cytokine alleles or haplotypes with AD...